$1.1 million order for Implant Sciences' portable explosives detectors

Published 12 September 2011

Implant Sciences Corporation, a developer of explosives detection technology, recently announced that it had received a $1.1 million order for its portable explosives detection systems; with the latest purchase, Implant Sciences will supply its Quantum Sniffer QS H-150 portable devices to the Middle East for use by critical infrastructure operators

Implant Sciences Corporation, a developer of explosives detection technology, recently announced that it had received a $1.1 million order for its portable explosives detection systems.

With the latest purchase, Implant Sciences will supply its Quantum Sniffer QS H-150 portable devices to the Middle East for use by critical infrastructure operators.

According to the company more than 1,300 QS H-150 units have been sold so far for use by governments and businesses across the world in aviation security, transportation security, cargo screening, and public safety.

“Unfortunately as ongoing threats of violence disrupt daily life in the Middle East, the need for portable explosives trace detection technology is increasing,” said Bruce Bower, the senior vice president of Implant Sciences. “The Quantum Sniffer is an excellent choice to improve security coverage because our QS-H150 has been uniquely engineered to reduce dirt and contamination clogging problems caused by sand and dust, which makes the unit highly available with little or no downtime required for system calibration or clear down following an alarm.”

The QS H-150 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives.

With automatic self-calibration, non-contact sampling, and no radioactive materials, the innovative QS-H150 continues to attract attention from new customers. We are very proud of the work our sales team and channel partners have invested in discovering this new opportunity,” said Glenn D. Bolduc, the CEO of Implant Sciences.